Source: International Congress 2016 – Non-inflammatory COPD monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Francesca Simioli (Naples, Italy), Francesca Simioli, Maria Martino, Giacomo Spurio Vennarucci, Lucia Morrone, Antonio Molino, Mauro Mormile, Anna Agnese Stanziola, Maria D’Amato. Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD. Eur Respir J 2016; 48: Suppl. 60, 3523

Member's Comments

No comment yet.

Related content which might interest you: Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 QVA149 provides superior peak lung function in patients with COPD Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Additive effect of targeted lung denervation plus drug in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Effects of tiotropium on lung function in current smokers and never smokers with asthma Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 LATE-BREAKING ABSTRACT: The novel inhaled dual PDE3/4 inhibitor RPL554 produces significant additional improvements in lung function when administered on top of existing standard of care in COPD patients Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016